Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mathilde Fréchet Jachym"'
Autor:
Yousra Kherabi, Mathilde Fréchet-Jachym, Christophe Rioux, Yazdan Yazdanpanah, Frédéric Méchaï, Valérie Pourcher, Jérôme Robert, Lorenzo Guglielmetti
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 9, Pp 1796-1804 (2022)
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional
Externí odkaz:
https://doaj.org/article/02df8e4ba8de4246b2e8b009dfa1db02
Autor:
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Eric Caumes, Mathilde Fréchet-Jachym, Jérôme Robert, Nicolas Veziris, Naira Khachatryan, Tinatin Kotrikadze, Armen Hayrapetyan, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 5, Pp 936-943 (2019)
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia,
Externí odkaz:
https://doaj.org/article/aca51c7af9fb4ceb917fdc54305dfd56
Autor:
Isabelle Bonnet, Elie Haddad, Lorenzo Guglielmetti, Pascale Bémer, Louis Bernard, Anne Bourgoin, Rachel Brault, Gaud Catho, Eric Caumes, Lélia Escaut, Eric Fourniols, Mathilde Fréchet-Jachym, Alice Gaudart, Hélène Guillot, Barthélémy Lafon-Desmurs, Jean-Philippe Lanoix, Philippe Lanotte, Adrien Lemaignen, Bénédicte Lemaire, Nadine Lemaitre, Christophe Michau, Philippe Morand, Faiza Mougari, Dhiba Marigot-Outtandy, Solène Patrat-Delon, Thomas Perpoint, Caroline Piau, Valérie Pourcher, Virginie Zarrouk, Valérie Zeller, Nicolas Veziris, Stéphane Jauréguiberry, Alexandra Aubry
Publikováno v:
Microorganisms, Vol 10, Iss 6, p 1215 (2022)
The optimal treatment for osteoarticular infection due to multidrug-resistant tuberculosis strains (MDR-OATB) remains unclear. This study aims to evaluate the diagnosis, management and outcome of MDR-OATB in France. We present a case series of MDR-OA
Externí odkaz:
https://doaj.org/article/d9bac177e0e64bcbaa45d9d063159bc8
Autor:
Johannes, Eimer, Mathilde, Fréchet-Jachym, Damien, Le Dû, Eric, Caumes, Najoua, El-Helali, Dhiba, Marigot-Outtandy, Frédéric, Mechai, Gilles, Peytavin, Valérie, Pourcher, Christophe, Rioux, Yazdan, Yazdanpanah, Jérôme, Robert, Lorenzo, Guglielmetti
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Treatment of multidrug-resistant tuberculosis (MDR-TB) with linezolid is characterized by high rates of adverse events. Evidence on therapeutic drug monitoring to predict drug toxicity is scarce. This study aimed to evaluate the association of linezo
Autor:
Elena Sumarokova, Gina Gualano, Evgeny Belilovski, Armine Izadifar, Eva Tabernero, Pierre Bachez, Alessandro Torre, Maria Luiza de Souza-Galvão, François-Xavier Blanc, Claire Andrejak, Mathilde Fréchet Jachym, Denise Rossato Silva, Paolo Scarpellini, Margarita Marín Royo, Dina Visca, Ángel Domínguez-Castellano, Teresa Rodrigo, Antoine Froissart, Damien Le Dû, Giovanni Sotgiu, Antonio Spanevello, Pierre-Alexandre Bart, Simon Tiberi, Miguel Zabaleta Murguiondo, Frédéric Schlemmer, Marina Tadolini, Rosella Centis, Matteo Saporiti, Sergey Borisov, Giovanni Battista Migliori, Vania Giacomet, Delia Goletti, Frédéric Rivière, Ilaria Motta, Samir Dourmane, Soazic Grard, José Cardoso-Landivar, José-María García-García, Jesica Mazza-Stalder, Fabrizio Palmieri, Luigi Codecasa, Catherine W.M. Ong, Adrián Sánchez-Montalvá, Lia D'Ambrosio, Jan-Willem C. Alffenaar, Paul A. Tambyah
Publikováno v:
The European Respiratory Journal
article-version (AM) Accepted Manuscript
The European respiratory journal, vol. 56, no. 1
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
European Respiratory Journal, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
article-version (AM) Accepted Manuscript
The European respiratory journal, vol. 56, no. 1
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
European Respiratory Journal, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems [1, 2]. SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe58fdd4efa3f56b2737cc2d5e084a8
http://hdl.handle.net/11383/2095863
http://hdl.handle.net/11383/2095863
Autor:
Christine Bernard, Florence Brossier, Mathilde Fréchet-Jachym, Philippe C. Morand, Sophie Coignard, Elisabeth Aslangul, Alexandra Aubry, Vincent Jarlier, Wladimir Sougakoff, Nicolas Veziris
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 506-507 (2014)
Externí odkaz:
https://doaj.org/article/b8e3bb89a6a14a88a753ab79eed661ce
Autor:
H. Guillot, G Thouvenin, J. Jaffré, Alexandra Aubry, Christine Bernard, Dhiba Marigot-Outtandy, B Henry, Valérie Pourcher, Florence Brossier, N. El Helali, Vincent Jarlier, D. Le Dû, Jérôme Robert, Nicolas Veziris, Laurent Raskine, B. Dautzenberg, Marie Jaspard, Claire Andrejak, B. Rivoire, Lorenzo Guglielmetti, Faiza Mougari, K. Chadelat, Mathilde Fréchet-Jachym
Publikováno v:
International Journal of Tuberculosis and Lung Disease
International Journal of Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, 2019, 23 (10), pp.1050-1054. ⟨10.5588/ijtld.18.0779⟩
International Journal of Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, 2019, 23 (10), pp.1050-1054. ⟨10.5588/ijtld.18.0779⟩
SETTING: The World Health Organization (WHO) recommends that multidrug-resistant tuberculosis (MDR-TB) treatment should be managed in collaboration with multidisciplinary advisory committees (consilia). A formal national Consilium has been establishe
Autor:
Naira Khachatryan, Lorenzo Guglielmetti, Nyasha Bakare, Mathieu Bastard, Nicolas Veziris, Holger J. Schünemann, Mathilde Fréchet-Jachym, Lawrence Mbuagbaw, Christian Lienhardt, Tinatin Kotrikadze, Zaza Avaliani, Catherine Hewison, Jérôme Robert, Eric Caumes, Armen Hayrapetyan
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2019, 25 (5), pp.936-943. ⟨10.3201/eid2505.181823⟩
Emerging Infectious Diseases, Vol 25, Iss 5, Pp 936-943 (2019)
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2019, 25 (5), pp.936-943. ⟨10.3201/eid2505.181823⟩
Emerging Infectious Diseases, Vol 25, Iss 5, Pp 936-943 (2019)
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15df076c4439dec078d26cc2bea38037
https://hal.archives-ouvertes.fr/hal-03127395
https://hal.archives-ouvertes.fr/hal-03127395
Autor:
Parvaneh Baghaei, Nicolas Veziris, Nesri Padayatchi, Anete Trajman, Timothy H. Holtz, Ying Cai, Janice Westenhouse, Ignacio Monedero, Sarah Smith, Vija Riekstina, Dick Menzies, Maria I. Rodriguez, Payam Tabarsi, Lia D'Ambrosio, Maia Kipiani, Didi Bang, Norbert Ndjeka, Suzanne M. Marks, Maryline Bonnet, Medea Gegia, Jan-Willem C. Alffenaar, James C.M. Brust, Ethel Leonor Noia Maciel, Zarir F Udwadia, Tae Sun Shim, Phil Lowenthal, Lorenzo Guglielmetti, Domingo Palmero, Carole D. Mitnick, Chi-Chiu Leung, Gerard de Vries, Shama D. Ahuja, Faiz Ahmad Khan, Sue Gu, Rafael Laniado-Laborín, Lawrence Mbuagbaw, Nakwon Kwak, Margareth Pretti Dalcolmo, Russell R. Kempker, Erika Mohr, Christoph Lange, Kathleen F. Walsh, Serena P. Koenig, Vladimir Milanov, Sundari Mase, Liga Kuksa, Tjip S. van der Werf, Kwok-Chiu Chang, Mayara Lisboa Bastos, Andrea Benedetti, Payam Nahid, Gregory P. Bisson, Geisa Fregona, Zhiyi Lan, Simon Tiberi, Won-Jung Koh, Eric Caumes, Jennifer Hughes, Maria Tarcela Gler, Keertan Dheda, Martin J. Boeree, Piret Viiklepp, Macarthur Charles, Nicola M. Zetola, Chawangwa Modongo, Barbara Seaworth, Eric Chung Ching Leung, Kathryn Schnippel, Ann C. Miller, Giovanni Battista Migliori, J. Peter Cegielski, Matteo Zignol, Kwonjune J. Seung, Digamber Behera, Salmaan Keshavjee, Laura F Anderson, Nafees Ahmad, Jérôme Robert, Afranio Lineu Kritski, Wing Wai Yew, Rupak Singla, Aliasgar Esmail, Mathilde Fréchet-Jachym, Ganzaya Sukhbaatar, Onno W. Akkerman, Rosella Centis, Stalz Charles Vilbrun, Pei-Chun Chan, Laura Jean Podewils, Edward D. Chan, Pei Zhi Li, Leah G. Jarlsberg, Sarah K. Brode, Charlotte Kvasnovsky, Jean W. Pape, Gregory J. Fox, Lisa Trieu, Ian R Reynolds, Petros Isaakidis, Pennan M. Barry, Vaira Leimane, Max R. O'Donnell, Andra Cirule, Myungsun Lee, Jae-Joon Yim, Giovanni Sotgiu, Jennifer Flood, Regina Gayoso
Publikováno v:
The Lancet (London), 392, 821-834
The Lancet (London), 392, 10150, pp. 821-834
LANCET, 392(10150), 821-834. ELSEVIER SCIENCE INC
The Lancet (London), 392, 10150, pp. 821-834
LANCET, 392(10150), 821-834. ELSEVIER SCIENCE INC
Item does not contain fulltext BACKGROUND: Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5589835d62745cbc34faee59b9dc46
http://hdl.handle.net/10029/622191
http://hdl.handle.net/10029/622191
Autor:
Jérôme Robert, Thomas Similowski, D. Le Dû, Nicolas Veziris, Eric Caumes, Marc Riquet, Mathilde Fréchet-Jachym, S. Morel, Pierre Mordant, Benoît Henry, F. Le Pimpec-Barthes
Publikováno v:
Revue des Maladies Respiratoires. 31:511-524
Resume Introduction L’emergence de souches de Mycobacterium tuberculosis resistantes aux antibiotiques (MDR-TB) pose a nouveau la question du traitement chirurgical des cavernes pulmonaires localisees et difficiles a steriliser medicalement. Dans c